Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShares Repurchased
Ratios

Core Laboratories (CLB) Shares Repurchased (2022 - 2025)

Core Laboratories' Shares Repurchased history spans 4 years, with the latest figure at $2.7 million for Q4 2025.

  • For Q4 2025, Shares Repurchased fell 45.84% year-over-year to $2.7 million; the TTM value through Dec 2025 reached $12.4 million, up 134.19%, while the annual FY2025 figure was $12.4 million, 134.19% up from the prior year.
  • Shares Repurchased reached $2.7 million in Q4 2025 per CLB's latest filing, down from $5.0 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $5.0 million in Q3 2025 to a low of $1000.0 in Q1 2023.
  • Average Shares Repurchased over 4 years is $1.5 million, with a median of $905000.0 recorded in 2022.
  • The largest YoY upside for Shares Repurchased was 4495.45% in 2025 against a maximum downside of 45.84% in 2025.
  • A 4-year view of Shares Repurchased shows it stood at $1.6 million in 2022, then grew by 12.06% to $1.8 million in 2023, then skyrocketed by 174.89% to $4.9 million in 2024, then plummeted by 45.84% to $2.7 million in 2025.
  • Per Business Quant, the three most recent readings for CLB's Shares Repurchased are $2.7 million (Q4 2025), $5.0 million (Q3 2025), and $2.7 million (Q2 2025).